Stock ULTI ULTIMOVACS ASA
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Ultimovacs ASA

Equities

ULTI

NO0010851603

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-06-21 EDT 		5-day change 1st Jan Change
7.85 NOK +0.64% Intraday chart for Ultimovacs ASA -9.04% -93.61%
06-11 Ultimovacs Asa Provides Update from Phase I Study in Malignant Melanoma CI
05-07 Transcript : Ultimovacs ASA, Q1 2024 Earnings Call, May 07, 2024

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Ultimovacs ASA Announces Positive Three-Year Results of 71% Overall Survival Rate in Cohort 1 of UV1-103 Study in Metastatic Malignant Melanoma
CI
Ultimovacs : Cancer Vaccine Trial Shows 90% Survival Rate
MT
Ultimovacs ASA’ UV1 in Combination with Pembrolizumab Shows 60% Objective Response Rate in Advanced Melanoma Phase I data
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ULTI Stock
  4. News Ultimovacs ASA
  5. Analyst Reco.